Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022-MedSci.cn

Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022

DeSilva, MB; Mitchell, PK; Klein, NP; Dixon, BE; Tenforde, MW; Thompson, MG; Naleway, AL; Grannis, SJ; Ong, TC; Natarajan, K; Reese, SE; Zerbo, O; Kharbanda, AB; Patel, P; Stenehjem, E; Raiyani, C; Irving, SA; Fadel, WF; Rao, SCT; Han, JM; Reynolds, S; Davis, JM; Lewis, N; McEvoy, C; Dickerson, M; Dascomb, K; Valvi, NR; Barron, MA; Goddard, K; Vazquez-Benitez, G; Grisel, N; Mamawala, M; Embi, PJ; Fireman, B; Essien, IJ; Griggs, EP; Arndorfer, J; Gaglani, M

Mitchell, PK (通讯作者)，Westat Corp, 1600 Res Blvd, Rockville, MD 20850 USA.

Abstract

Background We assessed coronavirus disease 2019 (COVID-19) vaccination impact on illness severity among adults hospitalized with COVID-19, August 2021......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022

科室

工具

服务